In this episode, Staying the Course in Metastatic Breast Cancer, Dr. Joyce O’Shaughnessy and Marissa Marti-Smith talk about the importance of shared decision making and patient education. What do your patients need to know about the latest data on toxicities and toxicity management to help them better adhere to their treatment regimen?

Visit https://suitehome.atpointofcare.com/library/2685.03/page/0?subdomain=breastcancer to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

In this episode, Mapping the Pathway in Metastatic Breast Cancer, Dr. Joyce O’Shaughnessy and Dr. Reshma Mahtani take a deeper dive into the phosphatidylinositol 3-kinase (PI3K) and AKT inhibitors for the treatment of metastatic hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer. This episode will help you better understand these treatments as well as the causes of treatment resistance. Visit https://suitehome.atpointofcare.com/library/2685.02/page/0?subdomain=breastcancer to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

In this episode, Testing the Waters in Metastatic Breast Cancer, Dr. Joyce O’Shaughnessy and Dr. Michelle Shiller discuss biomarkers and the best practices in biomarker testing for patients with metastatic hormone receptor (HR)-positive and human epidermal growth factor 2 (HER2)-negative breast cancer. What do you need to know about this important topic to ensure the very best care for your patients?

Visit https://suitehome.atpointofcare.com/library/2685.01/page/0?subdomain=breastcancer to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.